Effects of Nicotine on Anxiety and Depression in Mice
Author Information
Author(s): Hayase Tamaki
Primary Institution: Department of Legal Medicine, Kyoto University
Hypothesis
The study investigates the time course of anxiety- and depression-related behavioral alterations induced by nicotine and the effects of anxiolytic and cannabinoid drugs.
Conclusion
The study found that nicotine induces overlapping anxiety- and depression-related symptoms in mice, which can be influenced by certain drugs.
Supporting Evidence
- Repeated nicotine treatments caused prolonged anxiety and depression symptoms in mice.
- The serotonin 1A antagonist WAY 100135 and the cannabinoid virodhamine showed strong effects against anxiety symptoms.
- Virodhamine was effective against depression symptoms in both single and repeated treatment groups.
Takeaway
Nicotine can make mice feel anxious and sad, and some medicines can help them feel better.
Methodology
Mice were treated with nicotine and tested for anxiety and depression using the elevated plus-maze and forced swimming tests.
Limitations
The study was conducted on mice, which may not fully represent human responses to nicotine.
Participant Demographics
Male ICR mice, aged 60-90 days.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website